Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Lois M. Mulligan. (2016) Progress and potential impact of RET kinase targeting in cancer. Expert Review of Proteomics 13:7, pages 631-633.
Read now
Read now
Joshua R Colombo & Richard O Wein. (2014) Cabozantinib for progressive metastatic medullary thyroid cancer: a review. Therapeutics and Clinical Risk Management 10, pages 395-404.
Read now
Read now
Articles from other publishers (14)
Xiaoli Zhang, Manhui Zhu, Laiqing Xie, Xiaodong Sun, Jiaowen Xu, Yang Guo, Dong Liu, Yunwei Shi, Xun Xu & E Song. (2020) Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization. Journal of Ophthalmology 2020, pages 1-16.
Crossref
Crossref
Cyril Garcia, Camille Buffet, Laila El Khattabi, Marthe Rizk-Rabin, Karine Perlemoine, Bruno Ragazzon, Jérôme Bertherat, Françoise Cormier & Lionel Groussin. (2019) MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer. Oncotarget 10:23, pages 2320-2334.
Crossref
Crossref
Rikke Milling, Daniela Grimm, Marcus Krüger, Jirka Grosse, Sascha Kopp, Johann Bauer, Manfred Infanger & Markus Wehland. (2018) Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension. International Journal of Molecular Sciences 19:10, pages 3258.
Crossref
Crossref
Lois M Mulligan. (2018) 65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine. Endocrine-Related Cancer 25:8, pages T189-T200.
Crossref
Crossref
Yaakov Cass, Thomas H Connor & Alexander Tabachnik. (2016) Safe handling of oral antineoplastic medications: Focus on targeted therapeutics in the home setting. Journal of Oncology Pharmacy Practice 23:5, pages 350-378.
Crossref
Crossref
Pankaj Kumar Singh, Harpreet Singh & Om Silakari. (2016) Kinases inhibitors in lung cancer: From benchside to bedside. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1866:1, pages 128-140.
Crossref
Crossref
E. Grande, J. Santamaría Sandi, J. Capdevila, E. Navarro González, C. Zafón Llopis, T. Ramón y Cajal Asensio, J. M. Gómez Sáez, P. Jiménez-Fonseca, G. Riesco-Eizaguirre & J. C. Galofré. (2015) Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI). Clinical and Translational Oncology 18:8, pages 769-775.
Crossref
Crossref
Mohsine Driowya, Aziza Saber, Hamid Marzag, Luc Demange, Rachid Benhida & Khalid Bougrin. (2016) Microwave-Assisted Synthesis of Bioactive Six-Membered Heterocycles and Their Fused Analogues. Molecules 21:4, pages 492.
Crossref
Crossref
Daniel C. McFarland, Indu Varier & Krzysztof Misiukiewicz. 2016. Controversies in Thyroid Surgery. Controversies in Thyroid Surgery
203
228
.
Qi. Zhang, Jin Sun, Tianshu Lu, Jinling Zhang, Chunnuan Wu, Lin Li, Zhonggui He, Yanfang Zhao & Xiaohong Liu. (2015) A rapid and sensitive LC-MS/MS method for evaluation of the absolute oral bioavailability of a novel c-Met tyrosine kinase inhibitor QBH-196 in rats. Biomedical Chromatography 29:11, pages 1650-1656.
Crossref
Crossref
Maikel Herbrink, Bastiaan Nuijen, Jan H.M. Schellens & Jos H. Beijnen. (2015) Variability in bioavailability of small molecular tyrosine kinase inhibitors. Cancer Treatment Reviews 41:5, pages 412-422.
Crossref
Crossref
Juan C. Galofré, Javier Santamaría Sandi, Jaume Capdevila, Elena Navarro González, Carles Zafón Llopis, Teresa Ramón y Cajal Asensio, José Manuel Gómez Sáez, Paula Jiménez-Fonseca, Garcilaso Riesco Eizaguirre & Enrique Grande. (2015) Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI). Endocrinología y Nutrición 62:4, pages e37-e46.
Crossref
Crossref
Gisela C. Muscia, Stephanie Hautmann, Graciela Y. Buldain, Silvia E. Asís & Michael Gütschow. (2014) Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase. Bioorganic & Medicinal Chemistry Letters 24:6, pages 1545-1549.
Crossref
Crossref
Álvaro Pinto. (2013) Cabozantinib: a novel agent with a dual mechanism of action for castration-resistant prostate carcinoma. Cancer Chemotherapy and Pharmacology 73:2, pages 219-222.
Crossref
Crossref